Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|July 15, 2024
Identification of mCMQ069, a novel antimalarial with potential for a single-dose cure and/or 28-day chemopreventionAnil K Gupta, James Pedroarena, Armen Nazarian, et al.The Journal of Pharmacology and Experimental Therapeutics|May 29, 2012
Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune diseaseEric J Tarcha, Victor Chi, Ernesto J Muñoz-Elías, et al.International Journal for Parasitology. Drugs and Drug Resistance|December 24, 2019
Short-course quinazoline drug treatments are effective in the Litomosoides sigmodontis and Brugia pahangi jird modelsMarc P Hübner, Emma Gunderson, Ian Vogel, et al.Biorxiv : the Preprint Server for Biology|April 12, 2022
Targeted protein S-nitrosylation of ACE2 as potential treatment to prevent spread of SARS-CoV-2 infectionChang-Ki Oh, Tomohiro Nakamura, Nathan Beutler, et al.Journal of Medical Virology|July 5, 2023
Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS-CoV-2 Omicron infectionWinnie Wan-Yee Tso, Mike Yat-Wah Kwan, Janette Siu-Yin Kwok, et al.Nature Chemical Biology|September 29, 2022
Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infectionChang-Ki Oh, Tomohiro Nakamura, Nathan Beutler, et al.Nature Communications|June 4, 2021
Drug repurposing screens identify chemical entities for the development of COVID-19 interventionsMalina A Bakowski, Nathan Beutler, Karen C Wolff, et al.Journal of Medicinal Chemistry|February 9, 2024
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel WarheadN G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.NPJ Genomic Medicine|August 10, 2019
Primary coenzyme Q10 deficiency-7: expanded phenotypic spectrum and a founder mutation in southern ChineseMullin Ho-Chung Yu, Mandy Ho-Yin Tsang, Sophie Lai, et al.Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.Pageof 4